Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

mipsagargin (G-202) / Rebus

NCT02082691: Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma

No Longer Available

N/A

G-202

Devalingam Mahalingam, GenSpera, Inc.

Hepatocellular Carcinoma

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites